DadFinStart your free weekRegencell Bioscience Holdings Limi (RGC) stock score
$9.59 ▲ +0.74% today
Regencell Bioscience Holdings Limi (RGC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, listed in Hong Kong. On DadFin's weekly run it scores 63.1 out of 100 on the Dad Score, a middling reading that places the business ahead of 63% of the 5,721 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #300 of 959. Its strongest axes are price action and liquidity; its weakest are valuation and quality.
Scores from the run of Oct 17, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →
The eight axes
Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.
Key numbers
What subscribers see on RGC
- Value Score: is the price right for this business, the score the Value book is selected on.
- Trader Score: is it set up to move, refreshed every 15 minutes in the session.
- The full eight-axis breakdown, every input and its percentile.
- SEC filings, insider buying, earnings history and peers side by side.
- Whether it is in this week's published books, with the receipts.
Drug Manufacturers - Specialty & Generic peers
| Stock | Company | Dad Score | Band |
|---|---|---|---|
| TAK | Takeda Pharmaceutical Company Limi | 86.4 | strong |
| TEVA | Teva Pharmaceutical Industries Lim | 97.5 | strong |
| HLN | Haleon plc | 95.1 | strong |
| ZTS | Zoetis Inc. | 91.1 | strong |
| UTHR | United Therapeutics Corporation | 98.5 | strong |
| VTRS | Viatris Inc. | 73.8 | good |
| NBIX | Neurocrine Biosciences, Inc. | 88.7 | strong |
| ELAN | Elanco Animal Health Incorporated | 98.4 | strong |
Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 17, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.